ARTICLE | Product Development
FDA authorizes first COVID-19 test using at-home saliva samples, begins unveiling serological test validation data
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
May 9, 2020 2:41 AM UTC
FDA’s authorization of a COVID-19 diagnostic from Rutgers University marks the first time the agency has signed off on detecting SARS-CoV-2 from saliva samples collected at home, which avoids the inconvenience of both in-office visits and invasive swabs.
The May 7 Emergency Use Authorization (EUA) comes on the heels of the first authorization for a CRISPR-based diagnostic, and the publication of the first data from an independent test validation initiative led by NCI...